Global Forum on Nicotine returns to examine nicotine’s future16.06.21
This month marks the eighth Global Forum on Nicotine (GFN), set to take place on 17-18th June in Liverpool, as well as online.
The theme for this year’s conference is the Future for Nicotine and according to event organisers, “will address some of the concerns prompted by recent reviews and reports (on the subject of tobacco harm reduction and nicotine) that will have an impact in different parts of the world.”
Dr Grant O’Connell, Head of Tobacco Harm Reduction Science at Imperial Brands, Fontem Ventures’ parent company, said: “We applaud the work of the Global Forum on Nicotine in highlighting the science and understanding of nicotine and its future, including through wider acceptance of potentially less harmful nicotine-containing products as an effective tobacco harm reduction tool for adult smokers.
“We believe next generation products such as e-vapour products have an important role to play in making a meaningful contribution to harm reduction and acknowledge the critical importance of ensuring the highest product standards are maintained across the industry in order to increase adult smoker trust.”
The conference schedule this year includes three keynote speeches, four panel sessions and two hosted sessions, which will be broadcasted for those not in attendance physically. A number of the formal presentations in the programme will also be posted on the GFN website in advance.
The conference website will also be hosting the GFN Fives, short multimedia presentations up to five minutes in length, which will be posted prior to the conference and will remain online as part of the archive site for the event.
This year’s theme, the Future for Nicotine, is particularly salient in 2021 as a growing number of public health experts seek to make further strides in the realm of tobacco harm reduction (THR) through advocating the use of potentially less harmful nicotine-containing products.
Tobacco harm reduction is integral to the values and mission of vaping brand blu and its manufacturer Fontem Ventures, who believes scientific substantiation and high product standards are paramount to convincing adult smokers that a viable alternative exists to combustible cigarettes. If adult smokers do not trust, and therefore choose to use, vaping products, and instead continue smoking, then the opportunity for tobacco harm reduction will be lost.
The company has conducted extensive scientific research on vaping, while a team of professional toxicologists and other specialists assess every single ingredient to ensure blu e-liquids are of the highest standard.